JBT-101 in Systemic Lupus Erythematosus (SLE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert B. Zurier, M.D.
Northwell Health
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology
La Jolla, California, United States
- Ucla Medical Center: Division of Rheumatology
Los Angeles, California, United States
- University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center
San Francisco, California, United States
- Yale University
New Haven, Connecticut, United States
- Emory University: Division of Rheumatology
Atlanta, Georgia, United States
- Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases
Manhasset, New York, United States
- Columbia University Medical Center: Department of Medicine, Division of Rheumatology
New York, New York, United States
- New York University Langone Medical Center: Department of Medicine, Division of Rheumatology
New York, New York, United States
- Bronx-Lebanon Hospital Center: Division of Rheumatology
The Bronx, New York, United States
- Duke University
Durham, North Carolina, United States
- Metrohealth Medical Center
Cleveland, Ohio, United States
- Penn State Ms Hershey Medical Center
Hershey, Pennsylvania, United States
- Temple University
Philadelphia, Pennsylvania, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center: Division of Rheumatology and Clinical Immunology
Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Dec 2017
- Primary completion
- 28 Jul 2021
- Completion
- 28 Jul 2021
- Last update posted
- 6 May 2026
- Registered enrollment
- 109
- Registry id
- NCT03093402
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.